Minimal Residual Disease Assessment in Colorectal Cancer (MiRDA-C) (CTMS# 22-0072)
The goal of this study is to learn if circulating tumor DNA and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come back or spread.